Our customers license exclusive rights to a combination of substance(s) – inhaler – geography. A technology access fee is paid for the exclusive rights. Iconovo develops an inhalation product for the customer and the customer compensates Iconovo by paying development milestones. Once the product is launched, the customer pays Iconovo royalties for the use of licensed intellectual property.
Iconovo offers reliable, competitively priced dry powder inhaler solutions based on four proprietary differentiated technical platforms. Collaborating with Iconovo will give the customer a unique inhaler product at reduced project risk, lower development cost and shorter time to market.